Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer

被引：0
|
作者：
Manegold, C [1 ]
机构：
[1] Thoraxklin, Dept Internal Med & Oncol, D-69126 Heidelberg, Germany
来源：
SEMINARS IN ONCOLOGY | 1998年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：18 / 22
页数：5
相关论文
共 50 条
  • [1] A randomized study of gemcitabine monotherapy versus Etoposide/Cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer
    Manegold, C
    Drings, P
    vonPawel, J
    Ricci, S
    Dornoff, W
    vanWalree, N
    Huinink, WT
    Chemaissani, A
    Stahel, P
    Bergman, B
    Wagenius, G
    Sederholm, C
    Mattson, K
    Liippo, K
    KellokumpuLehtinen, P
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 813 - 817
  • [2] Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
    Manegold, C
    Bergman, B
    Chemaissani, A
    Dornoff, W
    Drings, P
    KellokumpuLehtinen, P
    Liippo, K
    Mattson, K
    vonPawel, J
    Ricci, S
    Sederholm, C
    Stahel, RA
    Wagenius, G
    vonWalree, N
    tenBokkelHuinink, W
    ANNALS OF ONCOLOGY, 1997, 8 (06) : 525 - 529
  • [3] Single-agent activity of gemcitabine in advanced non-small cell lung cancer
    LeChevalier, T
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 36 - 42
  • [4] Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
    Huinink, WWT
    Bergman, B
    Chemaissani, A
    Dornoff, W
    Drings, P
    Kellokumpu-Lehtinen, PL
    Liippo, K
    Mattson, K
    von Pawel, J
    Ricci, S
    Sederholm, C
    Stahel, RA
    Wagenius, G
    von Walree, N
    Manegold, C
    LUNG CANCER, 1999, 26 (02) : 85 - 94
  • [5] Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: A review
    Hansen, HH
    Sorensen, JB
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : S38 - S41
  • [6] A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer
    Goksel, T
    Hatipoglu, ON
    Ozturk, C
    Gorguner, M
    Kiyik, M
    Yilmaz, U
    Guzelant, A
    Tasbakan, S
    Tabakoglu, E
    Firat, H
    Tutar, U
    Cikrikicioglu, S
    Akkoclu, A
    Soyer, S
    Cakir, E
    Itil, O
    Sanal, S
    RESPIROLOGY, 2005, 10 (04) : 456 - 463
  • [7] Concomitant Chemoradiotherapy with Etoposide & Cisplatin versus Docetaxel & Cisplatin in Locally Advanced Non-Small Cell Lung Cancer
    Eralp, Yesim
    Sen, Fatma
    Tambas, Makbule
    Ozkaya, Kubra
    Ozkan, Berker
    Oral, Ethem N.
    Saglam, Esra K.
    Firat, Pinar
    Saip, Pinar
    Toker, Alper
    Kizir, Ahmet
    Aydiner, Adnan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S655 - S656
  • [8] Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small cell lung cancer: a phase II study
    Scinto, AF
    Ferraresi, V
    Milella, M
    Tucci, E
    Santomaggio, C
    Pasquali-Lasagni, R
    Del Vecchio, MR
    Campioni, N
    Nardi, M
    Cognetti, F
    BRITISH JOURNAL OF CANCER, 1999, 81 (06) : 1031 - 1036
  • [9] Single-agent gemcitabine in non-small cell lung cancer: The French experience
    LeChevalier, T
    Gottfried, M
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : S47 - S49
  • [10] Single-agent mitomycin for advanced non-small cell lung cancer
    Snee, M
    CLINICAL ONCOLOGY, 2001, 13 (02) : 99 - 102
12345